Topical clindamycin phosphate demonstrated a highly significant decrease of inflammatory lesions of 72%, while tetracycline and placebo demonstrated a 57% and 12% decrease, respectively [ 12 ].
1
—
—
Topical clindamycin phosphate demonstrated a highly significant decrease of inflammatory lesions of 72%, while tetracycline and placebo demonstrated a 57% and 12% decrease, respectively [ 12 ].